Women's Health Devices Market Report Scope & Overview:

The Women's Health Devices Market was valued at USD 48.32 Billion in 2025 and is expected to reach USD 115.79 Billion by 2035, growing at a CAGR of 9.13% from 2026 to 2035.

The market for Women’s Health Devices is expected to continue its growth trend as a result of the significant rise in expenditure on the health of women worldwide. The major reason behind the rise in expenditures is the rising awareness about women’s health problems combined with the steady rise in the disposable income of women around the globe. The increased number of cases of cancer in women, specifically breast cancer and ovarian cancer, as well as uterine fibroids, are the factors propelling this market strongly, while the increasing number of young women are adopting these devices.

Hologic, headquartered in Marlborough, Massachusetts, continued expanding its breast health and diagnostic imaging portfolio in 2025, reinforcing its position as one of the world's leading dedicated women's health device companies serving hospitals and diagnostic imaging centers globally.

To Get more information On Women's Health Devices Market - Request Free Sample Report

Women's Health Devices Market Trends

• Growing awareness of female health issues continues driving sustained increases in women's health expenditure globally.
• Rising prevalence of female cancers, including breast and ovarian cancer, continues strengthening demand for diagnostic and treatment devices.
• The increasingly younger generation of women continues adopting women's health devices and technologies more intensely.
• Government initiatives and research funding programs continue supporting women's health technology development and access.
• Improved regulatory protections for reproductive health data continue supporting broader adoption of connected health devices.

The United States Women's Health Devices Market Outlook

The United States Women's Health Devices Market was valued at USD 18.77 Billion in 2025 and is expected to reach USD 45.67 Billion by 2035, growing at a CAGR of 9.30% from 2026 to 2035.

The USA was a front-runner in terms of demand for North America’s women’s health devices owing to advanced healthcare infrastructure and supportive government regulations, which include the development of better data protection laws for protecting reproductive health records. Almost 81% of women aged between eighteen to sixty-four years had a regular source of healthcare in the USA, indicating that more women were taking interest in their health, making the USA the largest market for this technology.

The United States government allocated approximately USD 500 million in 2024 through the National Institutes of Health and the Advanced Research Projects Agency for Health to improve women's health research and invention, reflecting a strategic push to address conditions including breast cancer, pelvic disorders, and reproductive health issues.

Women's Health Devices Market Segmentation Analysis

• By Product Type, the diagnostic imaging devices segment held the largest share in women's health devices market in 2025, while the surgical devices segment is the fastest growing.
• By Application, the breast health segment held the largest share in women's health devices market in 2025, while the reproductive health segment is the fastest growing.
• By Indication, the female cancers segment held the largest share in women's health devices market in 2025, while the pelvic disorders segment is the fastest growing.
• By End User, the hospitals clinics segment held approximately 48.00% share in women's health devices market in 2025, while the homecare settings segment is the fastest growing.

By Product Type, diagnostic imaging devices dominated the women's health devices market, surgical devices grew fastest

The diagnostic imaging devices segment held the largest product type share in 2025, anchored by breast and gynecological imaging technology that continues forming the foundation of early cancer detection and routine women's health screening programs. That established screening infrastructure keeps diagnostic imaging devices firmly at the top of the broader product type segmentation across nearly every major women's health program worldwide.

The surgical devices segment is projected to grow at the fastest CAGR during the forecast period, as minimally invasive gynecological surgical technology continues expanding treatment options for conditions including uterine fibroids and pelvic organ prolapse. Rising adoption of minimally invasive surgical approaches continues pushing this product type category's growth rate ahead of the broader product type segmentation.

By Application, breast health dominated the women's health devices market, reproductive health grew fastest

The breast health segment held the largest application share in 2025, driven by the increased prevalence of breast cancer that continues sustaining robust demand for screening, diagnostic, and treatment devices across nearly every major healthcare market. That sustained breast cancer screening demand keeps this application category firmly at the center of overall women's health devices demand worldwide.

The reproductive health segment is projected to grow at the fastest CAGR during the forecast period, as growing fertility technology investment and rising demand for family planning and reproductive monitoring devices continue expanding this application category. Rising consumer and clinical interest in fertility and reproductive health technology continues pushing this application category's growth rate ahead of the broader application segmentation.

By Indication, female cancers dominated the women's health devices market, pelvic disorders grew fastest

The female cancers segment held the largest indication share in 2025, anchored by the increased prevalence of breast and ovarian cancer that continues driving sustained demand for diagnostic and treatment devices across the broader women's health devices market. That substantial and growing patient population keeps female cancers firmly at the center of overall indication-based demand across nearly every major regional market worldwide.

The pelvic disorders segment, including uterine fibroids and related conditions, is projected to grow at the fastest CAGR during the forecast period, as rising awareness and improved diagnostic capability continue expanding the diagnosed patient population seeking treatment. Rising clinical attention to previously underdiagnosed pelvic health conditions continues pushing this indication category's growth rate ahead of the broader indication segmentation.

By End User, hospitals clinics dominated the women's health devices market, homecare settings grew fastest

The hospitals clinics segment held the largest end-user share in 2025, at approximately 48.00%, largely due to the linkage between complex diagnostics and the treatment of cancers and gynecological disorders that continue requiring specialized clinical settings. The adoption of advanced female health technologies, including gynecological diagnostic devices and breast health devices, continues being supported by government reimbursement policies and healthcare infrastructure investments that keep hospitals and clinics firmly at the top of the broader end-user segmentation.

The homecare settings segment is projected to grow at the fastest CAGR during the forecast period, as at-home diagnostic and monitoring devices continue expanding access for women managing fertility tracking, menstrual health, and menopause symptoms outside traditional clinical settings. Rising consumer comfort with self-administered health monitoring continues pushing this end-user category's growth rate ahead of the broader end-user segmentation.

Regional Analysis

North America Women's Health Devices Market Insights

North America held the largest share of the global Women's Health Devices Market in 2025, at approximately 45.70%, supported by strong healthcare expenditure for women's health and comparatively stronger demand for technologically advanced devices. Growing awareness of female health issues and sustained increases in women's disposable income continued reinforcing this leadership position throughout the year.

North America dominated the market with about 85.10% of regional revenue due to presence of the US companies that manufacture leading devices and the strong reimbursement structure in the country. Canada provided a rising share of regional revenue due to rising investments in the area of women’s health in the country and thus retained the first place in this market.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Women's Health Devices Market Insights

Europe held a substantial share of the global Women's Health Devices Market in 2025, supported by well-established national health insurance coverage and strong regulatory support for women's health technology across the continent. Germany accounted for roughly 27.30% of regional revenue, supported by its concentration of medical device manufacturers and comprehensive women's healthcare infrastructure.

France, the United Kingdom, and the Nordic countries followed a broadly similar trajectory, as continued government investment in women's health research extended device adoption across the continent's largest healthcare markets. Continued regulatory support for reproductive health technology is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific Women's Health Devices Market Insights

Asia Pacific was the fastest-growing region in the global Women's Health Devices Market, driven by rising healthcare infrastructure investment, growing female cancer awareness campaigns, and expanding disposable income among women across the region's largest and most populous economies. Rising government-backed women's health initiatives continued driving regional demand at a pace considerably faster than more mature Western markets.

China constituted about 36.20% of regional revenues, bolstered by increasing healthcare infrastructure within the country and increasing awareness of women’s health programs. Japan and South Korea generated considerable additional regional demand via their respective adoption of advanced healthcare technology, further cementing the Asia Pacific region as the obvious market leader.

MEA & Latin America Women's Health Devices Market Insights

Growth was witnessed in the adoption of women's health device solutions in the Middle East & Africa region during 2025 on account of increased investments made in the healthcare infrastructure and increasing involvement of governments in women's health screening campaigns in the Gulf countries, especially. The revenue contribution from UAE in the region stood at around 26.50%.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.40% of regional revenue, where growing women's healthcare infrastructure investment continued to support category growth. Mexico and Argentina followed a similar trajectory as regional women's health technology adoption expanded further through the remainder of the forecast period.

Growth Drivers: Rising health expenditure and female cancer prevalence

There has been a strong increase in women's health expenditure globally, primarily due to growing awareness of female health issues and the sustained increase in disposable incomes of women across the world. The increased prevalence of female cancers such as breast and ovarian cancer, along with other conditions such as uterine fibroids, continues driving the market strongly across nearly every major regional healthcare system.

The increasingly younger generation of women continues adopting women's health devices and technologies intensely, reflecting a broader generational shift toward proactive health management. Government initiatives, including national women's health research funding programs and improved regulatory protections for reproductive health data, continue reinforcing structural demand growth across the broader women's health devices market.

Restraints: High device costs and unequal healthcare access

High initial costs continue restricting adoption among smaller healthcare facilities and price-sensitive patient populations, particularly for advanced diagnostic imaging and surgical device technology. That cost barrier continues concentrating the most advanced women's health technology within larger, well-capitalized healthcare systems.

Unequal access to advanced preventive healthcare technologies remains a major barrier, particularly in rural and underserved regions where healthcare infrastructure has not kept pace with growing demand for women's health screening and treatment. That access gap continues requiring sustained public health investment to extend women's health technology to historically underserved populations.

Opportunities: Homecare device expansion and reproductive health technology innovation

Growing adoption of at-home diagnostic and monitoring devices presents substantial opportunity for manufacturers positioned to serve women managing fertility tracking, menstrual health, and menopause symptoms outside traditional clinical settings. Manufacturers capable of delivering accurate, user-friendly homecare devices stand to capture a growing share of demand as this care model continues expanding.

Continued innovation in reproductive health and fertility technology presents a further significant growth avenue, as growing investment in this application category continues expanding treatment and monitoring options for women. Manufacturers capable of delivering genuinely differentiated reproductive health technology stand to capture meaningful new revenue streams through 2035.

Recent Developments:

• 2025: The Cooper Companies continued expanding its women's health and fertility technology portfolio through its CooperSurgical division, strengthening its position serving reproductive health and gynecological surgery customers.
• 2025: GE HealthCare continued advancing its women's health imaging technology, targeting hospitals and diagnostic centers seeking improved breast and gynecological imaging capability.
• 2026: Hologic received U.S. FDA clearance for the Genius Digital Diagnostics System with the Genius Cervical AI algorithm, enhancing AI-assisted cervical cancer screening and strengthening its women's health diagnostics portfolio.

Women's Health Devices Market key players are:

• F. Hoffmann-La Roche Ltd.
• Hologic, Inc.
• Becton, Dickinson and Company
• GE HealthCare
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Medtronic plc
• Boston Scientific Corporation
• The Cooper Companies, Inc.
• Bayer AG
• Teleflex Incorporated
• Merit Medical Systems, Inc.
• Natera, Inc.
• Exact Sciences Corporation
• Myriad Genetics, Inc.
• Organon & Co.
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Canon Medical Systems Corporation
• Abbott Laboratories

Women's Health Devices Market Report Scope :